News

When a company of Pfizer's caliber trades at these valuation levels, either the market is correctly anticipating a permanent deterioration in business fundamentals, or it's presenting a ...
In “Sister, Sinner,” Claire Hoffman tells the stranger-than-fiction story of Aimee Semple McPherson, whose mysterious life made headlines in the 1920s.
Kirsten is Marketing Director for Mondelez International where she heads up the Meals business spanning two of the UK’s top brands, Philadelphia & Dairylea. Her formative years were spent at P&G where ...
Along with the track comes a self-directed video which reimagines a '90s Calvin Klein advert alongside a cast of Naomi Mcpherson, Cara Delevigne, Towa Bird, ER Fightmaster, and other “hot mascs” that ...
If you're looking for an undervalued growth stock to buy right now, Pfizer (PFE 0.30%) is an investment that should be near the top of your list. While the company is facing a challenging road ...
Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO Jeff Smith.
The Pfizer plant in McPherson laid off 80 people, KSN News confirmed on Thursday. Those impacted included professional/salaried employees, and production was not impacted.
WICHITA, Kan. (KSNW) – The Pfizer plant in McPherson laid off 80 people, KSN News confirmed on Thursday. Those impacted included professional/salaried employees, and production was not impacted.
Pfizer’s revenue rose at an average annual rate of 25.6% from $41.7 billion in 2020 to $58.5 billion in 2023, while AbbVie’s revenue grew at an average rate of 6.5% from $45.8 billion to $54.3 ...
The State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection violations related to the company's manufacturing of the COVID-19 vaccine.
The downsides of a deal to acquire Viking Let's first look at the potential downsides to Pfizer acquiring Viking. One especially stands out: Pfizer already has two weight-loss candidates in its ...
If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourla is, unfortunately, the worst. My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels.